Generic name |
tiotropium (Handihaler® ONLY) |
---|---|
Strength |
18 mcg |
Form |
dry powder for oral inhalation |
Special Authority criteria |
Approval period |
---|---|
Diagnosis of chronic obstructive pulmonary disease (COPD) AND Failure after a minimum one-month trial of EACH of the regular benefit long-acting muscarinic receptor antagonist (LAMA) products (see notes) |
Indefinite |
The Regular Benefit LAMA products are the following: